MedPath

Generation of induced pluripotent stem cells from patients with genetic neurodevelopmental disorders to study disease mechanisms

Recruiting
Conditions
genetic disorders of brain development
10029299
Registration Number
NL-OMON44331
Lead Sponsor
Erasmus MC, afdeling Klinische Genetica
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

patients with genetic causes of neurodevelopmental disorders. In principle patients of all ages are eligible, as some forms of neurodevelopmental disorders present already at young age. Healthy individuals either related or unrelated to the patient.

Exclusion Criteria

-Patient tested as HIV or hepatitis positive.
-Healthy control individuals: Partners of patients and employees of Erasmus MC department of Clinical Genetics are excluded.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>the generation of iPS cells from patient material (blood or skin cells), that<br /><br>have either already been sampled during the diagnostic work-up of the patients,<br /><br>or will be collected when other procedures are scheduled. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>the generation of disease models from the generated iPS cells which will allow<br /><br>further functional investigations into the disease mechanisms. </p><br>
© Copyright 2025. All Rights Reserved by MedPath